Investigational drugs in phase I and phase II clinical trials for thalassemia
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Investigational drugs in phase I and phase II clinical trials for thalassemia
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 26, Issue 7, Pages 793-802
Publisher
Informa UK Limited
Online
2017-05-25
DOI
10.1080/13543784.2017.1335709
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gene Therapy for β-Hemoglobinopathies
- (2017) Marina Cavazzana et al. MOLECULAR THERAPY
- Sickle Cell Disease
- (2017) Frédéric B. Piel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Forced chromatin looping raises fetal hemoglobin in adult sickle cells to higher levels than pharmacologic inducers
- (2016) L. Breda et al. BLOOD
- A randomized trial of amlodipine in addition to standard chelation therapy in patients with thalassemia major
- (2016) J. L. Fernandes et al. BLOOD
- Minihepcidin peptides as disease modifiers in mice affected by -thalassemia and polycythemia vera
- (2016) C. Casu et al. BLOOD
- Transplantation for thalassemia major
- (2016) Franco Locatelli et al. CURRENT OPINION IN HEMATOLOGY
- Progress Toward the Control and Management of the Thalassemias
- (2016) Suthat Fucharoen et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the βA(T87Q)-GlobinGene
- (2016) Olivier Negre et al. HUMAN GENE THERAPY
- Cell and Gene Therapy for the Beta-Thalassemias: Advances and Prospects
- (2016) Jorge Mansilla-Soto et al. HUMAN GENE THERAPY
- CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
- (2016) Daniel P. Dever et al. NATURE
- A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition
- (2016) Elizabeth A Traxler et al. NATURE MEDICINE
- Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia
- (2016) Lin Ye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice
- (2016) Zhanhui Ou et al. Scientific Reports
- Combination therapy with aTmprss6RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermedia
- (2015) Paul J. Schmidt et al. AMERICAN JOURNAL OF HEMATOLOGY
- Growth Differentiation Factor 15 expression and regulation during erythroid differentiation in non-transfusion dependent thalassemia
- (2015) Luisa Ronzoni et al. BLOOD CELLS MOLECULES AND DISEASES
- Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia
- (2015) C. Casu et al. HAEMATOLOGICA
- -thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies
- (2015) S. Rivella HAEMATOLOGICA
- BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
- (2015) Matthew C. Canver et al. NATURE
- Therapeutic genome editing: prospects and challenges
- (2015) David Benjamin Turitz Cox et al. NATURE MEDICINE
- Both TALENs and CRISPR/Cas9 directly target the HBB IVS2–654 (C > T) mutation in β-thalassemia-derived iPSCs
- (2015) Peng Xu et al. Scientific Reports
- Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia
- (2015) C. Casu et al. HAEMATOLOGICA
- -thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies
- (2015) S. Rivella HAEMATOLOGICA
- Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia
- (2015) C. M. Niemeyer et al. HAEMATOLOGICA
- Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine -thalassemia
- (2014) R. N. V. S. Suragani et al. BLOOD
- Reactivation of Developmentally Silenced Globin Genes by Forced Chromatin Looping
- (2014) Wulan Deng et al. CELL
- Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel
- (2014) E. Angelucci et al. HAEMATOLOGICA
- β-Thalassemia and Polycythemia vera: Targeting chronic stress erythropoiesis
- (2014) Bart J. Crielaard et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia
- (2014) Michael Dussiot et al. NATURE MEDICINE
- Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis
- (2014) Rajasekhar N V S Suragani et al. NATURE MEDICINE
- HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
- (2014) Loren Gragert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Three fingers on the switch
- (2013) Michael R. Tallack et al. CURRENT OPINION IN HEMATOLOGY
- Transcriptional regulators Myb and BCL11A interplay with DNA methyltransferase 1 in developmental silencing of embryonic and fetal β-like globin genes
- (2013) Mark Roosjen et al. FASEB JOURNAL
- Transcription Activator-like Effector Nuclease (TALEN)-mediated Gene Correction in Integration-free β-Thalassemia Induced Pluripotent Stem Cells
- (2013) Ning Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia
- (2013) Pedro Ramos et al. NATURE MEDICINE
- Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Anemia
- (2013) G. Lucarelli et al. Cold Spring Harbor Perspectives in Medicine
- Controlling Long-Range Genomic Interactions at a Native Locus by Targeted Tethering of a Looping Factor
- (2012) Wulan Deng et al. CELL
- Changing patterns of splenectomy in transfusion-dependent thalassemia patients
- (2011) Antonio Piga et al. AMERICAN JOURNAL OF HEMATOLOGY
- Hepcidin and iron regulation, 10 years later
- (2011) T. Ganz BLOOD
- Elevated liver iron concentration is a marker of increased morbidity in patients with thalassemia intermedia
- (2011) K. M. Musallam et al. HAEMATOLOGICA
- Genetic Therapy for Beta-Thalassemia: From the Bench to the Bedside
- (2011) P. Arumugam et al. Hematology-American Society of Hematology Education Program
- Targeted Therapeutic Strategies for Fetal Hemoglobin Induction
- (2011) V. G. Sankaran Hematology-American Society of Hematology Education Program
- Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists
- (2010) Christopher C. Rider et al. BIOCHEMICAL JOURNAL
- Therapeutic levels of fetal hemoglobin in erythroid progeny of -thalassemic CD34+ cells after lentiviral vector-mediated gene transfer
- (2010) A. Wilber et al. BLOOD
- The inherited diseases of hemoglobin are an emerging global health burden
- (2010) D. J. Weatherall BLOOD
- Thalassemia: An Overview of 50 Years of Clinical Research
- (2010) Vijay G. Sankaran et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- KLF1 regulates BCL11A expression and γ- to β-globin gene switching
- (2010) Dewang Zhou et al. NATURE GENETICS
- Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study
- (2009) A. T. Taher et al. BLOOD
- Induction of endogenous γ-globin gene expression with decoy oligonucleotide targeting Oct-1 transcription factor consensus sequence
- (2009) Xiaoxin S Xu et al. Journal of Hematology & Oncology
- Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in -thalassemia
- (2008) I. V. Libani et al. BLOOD
- Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study of ACE-011 (ActRIIA-IgG1) in Postmenopausal Women*
- (2008) Jon Ruckle et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Hydroxyurea for the Treatment of Sickle Cell Anemia
- (2008) Orah S. Platt NEW ENGLAND JOURNAL OF MEDICINE
- Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific RepressorBCL11A
- (2008) Vijay G. Sankaran et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started